Medpace (NASDAQ:MEDP) Upgraded by Zacks Investment Research to Buy

Medpace} stock has undergone multiple analysts rating changes in the recent past.  Medpace Upgraded by Zacks Investment Research on 10/28/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Medpace (NASDAQ:MEDP) Upgraded by Zacks Investment Research to Buy